Form 4: Axogen's Chief Innovation Officer, Erick Wayne DeVinney, Reports Stock Transactions

Erick Wayne DeVinney, Chief Innovation Officer of Axogen, Inc., reports the vesting and sale of restricted stock units to cover tax obligations.

Summary

• On March 16, 2024, Erick Wayne DeVinney, Chief Innovation Officer of Axogen, Inc., had restricted stock units vest.
• These vested units converted into 3,000, 2,950, and 12,725 shares of common stock.
• On March 21, 2024, DeVinney sold 716, 721, and 3,141 shares of common stock at a price of $7.68 per share.
• These sales were to cover tax withholding obligations related to the vesting of the restricted stock units.
• Following these transactions, DeVinney directly owns 177,474 shares of Axogen, Inc. common stock and 15,675 restricted stock units.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

This filing is a routine disclosure of insider transactions, which are common for executives who receive stock-based compensation. It provides transparency into the trading activities of company insiders.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the sale of shares, but it is primarily related to tax obligations of the reporting person.
• The impact on other stakeholders (employees, customers, suppliers, creditors) is likely negligible.

Key Dates